AK139 clinical trials
Also written AK139.
How each study uses AK139 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the AK139 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AK139
- 6
By phase
A phase 1/2 study counts in both.
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4
Studies that test AK139.
- Dec 2026A Study to Evaluate the Efficacy and Safety of AK139 in Participants With AsthmaPhase 2 · Akeso
- Apr 2027A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal PolypsPhase 2 · Akeso
- Aug 2027A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.Phase 2 · Akeso
- Nov 2027A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic DermatitisPhase 2 · Akeso
Studies
Open first, then newest update. How each study uses AK139 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.Not yet recruitingPhase 2AkesoNCT07883213Written as AK139
- A Trial to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Spontaneous UrticariaNot yet recruitingPhase 2AkesoNCT07875426Written as AK139
- A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal PolypsNot yet recruitingPhase 2AkesoNCT07755371Written as AK139
- A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic DermatitisNot yet recruitingPhase 2AkesoNCT07502222Written as AK139
- A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic RhinitisNot yet recruitingPhase 2AkesoNCT07436234Written as AK139
- A Study to Evaluate the Efficacy and Safety of AK139 in Participants With AsthmaNot yet recruitingPhase 2AkesoNCT07436221Written as AK139
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.Oct 20, 2026NCT07883213